中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
11期
4727-4730
,共4页
任勇军%赵彩霞%杨林%缪南东%邓进
任勇軍%趙綵霞%楊林%繆南東%鄧進
임용군%조채하%양림%무남동%산진
癌,肝细胞%化学栓塞,治疗性%导管消融术
癌,肝細胞%化學栓塞,治療性%導管消融術
암,간세포%화학전새,치료성%도관소융술
Carcinoma,hepatocellular%Chemoembolization,therapeutic%Catheter ablation
目的探讨射频消融术( RFA)联合肝动脉灌注化疗栓塞术( TACE)治疗中晚期原发性肝细胞癌(HCC)的疗效。方法133例中晚期HCC患者分为两组:单纯RFA组(72例),行RFA治疗115次;联合治疗组(61例),RFA治疗后再行TACE治疗,其中RFA 93次,TACE 134次。两组治疗结束后第3、6个月复查CT、AFP进行疗效评价,并随访1、2、3年生存率。结果单纯组和联合组术后3、6个月的有效率分别为73.61%、90.16%( P<0.05)和63.88%、85.25%( P<0.05)。单纯组和联合组术后3、6个月的AFP分别为(953.36±251.77)μg/L、(537.75±102.52)μg/L ( P<0.05)和(591.20±106.81)μg/L、(317.75±62.69)μg/L( P<0.05)。单纯组和联合组1、2、3年生存率分别为80.56%、66.67%、48.61%和95.08%、77.05%、57.38%。常见不良反应主要是发热、疼痛、转氨酶升高等,经对症处理后均能缓解。结论 RFA联合TACE治疗中晚期原发性肝细胞癌是一种有效的治疗方法,可以有效地控制病灶,延长患者的生存期。
目的探討射頻消融術( RFA)聯閤肝動脈灌註化療栓塞術( TACE)治療中晚期原髮性肝細胞癌(HCC)的療效。方法133例中晚期HCC患者分為兩組:單純RFA組(72例),行RFA治療115次;聯閤治療組(61例),RFA治療後再行TACE治療,其中RFA 93次,TACE 134次。兩組治療結束後第3、6箇月複查CT、AFP進行療效評價,併隨訪1、2、3年生存率。結果單純組和聯閤組術後3、6箇月的有效率分彆為73.61%、90.16%( P<0.05)和63.88%、85.25%( P<0.05)。單純組和聯閤組術後3、6箇月的AFP分彆為(953.36±251.77)μg/L、(537.75±102.52)μg/L ( P<0.05)和(591.20±106.81)μg/L、(317.75±62.69)μg/L( P<0.05)。單純組和聯閤組1、2、3年生存率分彆為80.56%、66.67%、48.61%和95.08%、77.05%、57.38%。常見不良反應主要是髮熱、疼痛、轉氨酶升高等,經對癥處理後均能緩解。結論 RFA聯閤TACE治療中晚期原髮性肝細胞癌是一種有效的治療方法,可以有效地控製病竈,延長患者的生存期。
목적탐토사빈소융술( RFA)연합간동맥관주화료전새술( TACE)치료중만기원발성간세포암(HCC)적료효。방법133례중만기HCC환자분위량조:단순RFA조(72례),행RFA치료115차;연합치료조(61례),RFA치료후재행TACE치료,기중RFA 93차,TACE 134차。량조치료결속후제3、6개월복사CT、AFP진행료효평개,병수방1、2、3년생존솔。결과단순조화연합조술후3、6개월적유효솔분별위73.61%、90.16%( P<0.05)화63.88%、85.25%( P<0.05)。단순조화연합조술후3、6개월적AFP분별위(953.36±251.77)μg/L、(537.75±102.52)μg/L ( P<0.05)화(591.20±106.81)μg/L、(317.75±62.69)μg/L( P<0.05)。단순조화연합조1、2、3년생존솔분별위80.56%、66.67%、48.61%화95.08%、77.05%、57.38%。상견불량반응주요시발열、동통、전안매승고등,경대증처리후균능완해。결론 RFA연합TACE치료중만기원발성간세포암시일충유효적치료방법,가이유효지공제병조,연장환자적생존기。
Objective To investigate the therapeutic effect of radiofrequency ablation ( RFA ) combined transcatheter arterial chemoembolization ( TACE) for management of advanced stage hepatocellular carcinoma ( HCC) . Methods 133 cases of HCC patients,were divided into two groups.The RFA Group,72 cases,was undergone 115 times of RFA.The Combined Group,61 cases,was performed TACE after RFA,93 times of RFA and 134 times of TACE.Two groups were evaluated the therapeutic effect after 3 and 6 months by CT and AFP.The survival rate(1,2, 3 years) were followed up.Results The effective power of the RFA Group and the Combined Group after 3 and 6 months were 73.61%,90.16%(P<0.05)and 63.88%,85.25%(P<0.05),respectively.AFP of the RFA Group and the Combined Group after 3 and 6 months were(953.36 ±251.77)μg/L,(537.75 ±102.52)μg/L(P<0.05) and(591.20 ±106.81)μg/L,(317.75 ±62.69)μg/L(P<0.05),respectively.The survival rate of the RFA Group and the Combined Group in 1,2,3 years were 80.56%,66.67%,48.61% and 95.08%,77.05%,57.38%, respectively .The complication of fervescence , ache and increased transaminase was released after treatment . Conclusion The RFA combined TACE was regarded as an effective treatment in advanced stage HCC , could significantly control tumor and to increase live time .